Home
iVascular

iVascular Market Share Analysis for July 2026

Catheters for the treatment of endovascular stenotic, restenotic or occlusive lesions, endovascular injuries and ischemic stroke.

Health > Health - Other

Domainivascular.global

Year Founded2010

Employees51 - 200

Annual Revenue$25M - $50M

iVascular

iVascular (including company regionals)

ivascular.global

See more website traffic and engagement information

iVascular Revenue up to July 2026 is 25M - 50M

revenue generated by iVascular top domains

iVascular top domains revenue over 3 years

Revenue for iVascular top domains

ivascular.global25M - 50M

See more with Sales Intelligence

Total visits to iVascular's top domains

Understand iVascular market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ivascular.global4.7K

See more with Sales Intelligence

Avg. visit duration in iVascular's top domains

Analyze iVascular engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ivascular.global00:00:21

See more with Sales Intelligence

Avg. pageviews on iVascular's top domains

See how iVascular keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ivascular.global1.50

See more with Sales Intelligence

iVascular top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by iVascular

These are the website technologies, by industry, used by iVascular top domains

Widget (8)

Twemoji

Mobile (3)

Meta Viewport

Advertising (2)

Google Adsense

Content Management System (2)

WordPress

More Technologies

9

See all

News & Signals from iVascular

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsiVascular attends event Kuala Lumpur Vascular Access Conference & Dialysis Access Synergy Conference 2024.At the Kuala Lumpur Vascular Access Conference & Dialysis Access Synergy Conference 2024 (KLVAC+DASy), its trusted partner, iVascular, featured the Luminor Paclitaxel drug-coated balloon (DCBs) designed to enhance outcomes in vascular access maintenance and the treatment of stenotic lesions in dialysis patients.

NewsAbbott partnered with iVascular on Aug 1st '23.For instance, Abbott Laboratories announced a cooperation with iVascular in August 2023 to develop and market bioabsorbable self-expanding stents for peripheral artery disease.

NewsiVascular launched Essential Pro on Jun 1st '20.For instance, in June 2020, iVascular S.L.U., a Spain-based medical device company, launched the Essential Pro, a novel reliable drug-coated balloon with hydrophilic coating technology applied in the distal shaft to reduce friction during navigation.